Abstract:Background and purpose: Recently, a number of mimics of the second messenger cyclic ADP-ribose (cADPR) with replacement of adenosine by inosine were introduced. In addition, various alterations in the molecule ranging from substitutions at C8 of the base up to full replacement of the ribose moieties still retained biological activity. However, nothing is known about the metabolic stability and cellular effects of these novel analogues.Experimental approach: cADPR and the inosine-based analogues were incubated with CD38, ADP-ribosyl cyclase and NAD-glycohydrolase and metabolism was analysed by RP-HPLC. Furthermore, the effect of the analogues on cytokine expression and proliferation was investigated in primary T-lymphocytes and T-lymphoma cells.Key results: Incubation of cADPR with CD38 resulted in degradation to adenosine diphosphoribose. ADP-ribosyl cyclase weakly catabolised cADPR whereas NAD-glycohydrolase showed no such activity. In contrast, N1-cyclic inosine 5'-diphosphoribose (N1-cIDPR) was not hydrolyzed by CD38. Three additional N1-cIDPR analogues showed a similar stability. Proliferation of Jurkat T-lymphoma cells was inhibited by N1-cIDPR, N1-[(phosphoryl-O-ethoxy)-methyl]-N9-[(phosphoryl-Oethoxy)methyl]-hypoxanthine-cyclic pyrophosphate (N1-cIDP-DE) and N1-ethoxymethyl-cIDPR (N1-cIDPRE). In contrast, in primary T cells neither proliferation nor cytokine expression was affected by these compounds.Conclusions and Implications: The metabolic stability of N1- cIDPR and its analogues provides an advantage for the development of novel pharmaceutical compounds interfering with cADPR mediated Ca2+ signalling pathways. The differential effects of N1-cIDPR and N1-cIDPRE on proliferation and cytokine expression in primary T cells versus T-lymphoma cells may constitute a starting point for novel anti-tumor drugs.

Synthesis and Biological Evaluation of Novel Membrane-Permeant Cyclic ADP-Ribose Mimics: N-[(5‘ ‘-O-phosphorylethoxy)methyl]-5‘-o-phosphorylinosine 5‘,5‘ ‘-Cyclicpyrophosphate (cidpre) and 8-Substituted Derivatives

A Novel Fluorescent Cell Membrane-permeable Caged Cyclic ADP-ribose Analogue

Synthesis And Calcium Mobilization Activity Of Cadpr Analogues Which Integrate Nucleobase, Northern And Southern Ribose Modifications

Trifluoromethylated Cyclic-Adp-ribose Mimic: Synthesis of 8-Trifluoromethyl-n(1)-[(5''-o-phosphorylethoxy)methyl]-5'-o-phosphorylinosine-5',5''-cyclic Pyrophosphate (8-Cf(3)-cidpre) and Its Calcium Release Activity in T Cells.

Cyclic Adenosine 5'-Diphosphoribose (cadpr) Mimics Used As Molecular Probes in Cell Signaling.

A Cell Permeable NPE Caged ADP-Ribose for Studying TRPM2

Chemical Synthesis,Characterization and Biological Properties of a Novel Cyclic ADP-Ribose Analogue

Cellular Effects and Metabolic Stability of N1-cyclic Inosine Diphosphoribose and Its Derivatives.

Studies on Cyclic ADP-ribose (cADPR) Analogues: Synthesis and Calcium Release Activity

Synthesis and Agonist Activity of Cyclic ADP-ribose Analogues with Substitution of the Northern Ribose by Ether or Alkane Chains.

Adenine-Based Calcium Signal Pathway Messengers: Synthesis and Agonistic Properties of Cyclic Adp-Ribose Analogs

A Minimal Structural Analogue Of Cyclic Adp-Ribose - Synthesis And Calcium Release Activity In Mammalian Cells

Syntheses and Calcium-Mobilizing Evaluations of N1-glycosyl-substituted Stable Mimics of Cyclic ADP-ribose.

Calcium‐Mobilizing Behaviors of Neutral Cyclic ADP‐Ribose Mimics That Integrate Modifications to the Nucleobase, Northern Ribose and Pyrophosphate

A Minimal Structural Analogue of Cyclic ADP-ribose

Design and Synthesis of Cadpr Analogues with Simplified Ribose and Nucleobase

Selective Inhibition of TRPM2 Channel by Two Novel Synthesized ADPR Analogues

Novel Nucleobase-Simplified Cyclic ADP-ribose Analogue: A Concise Synthesis and Ca(2+)-mobilizing Activity in T-lymphocytes.

Preparation of Cyclic ADP-ribose Antagonists and Caged Cyclic ADP-ribose.

A Novel Membrane-Permeant Cadpr Antagonist Modified in the Pyrophosphate Bridge.